Lawrence P Kane

32PUBLICATIONS
109CO-AUTHORS
Molecular targetsTumour immunologyAllergyMedical roboticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jul 15, 2026
Tim-3 Sustains Tumor Treg Stability and Function, Limiting Checkpoint Blockade Therapy Efficacy.

|Jun 05, 2026
ATR kinase inhibitors induce mitochondrial fission in CD8+ T cells and impair immune memory in vivo.

|Jun 04, 2026
T cell-specific loss of IRF1 results in defective CD8 T cell activation and antitumor immunity.

|Feb 20, 2026
Allergic airway reactions rewired by PI3Kδ mutation.

Lawrence P Kane

|Aug 12, 2025
Pik3ip1/TrIP Regulation of PI3K Restricts CD8 T Cell Anti-Tumor Immunity.

Benjamin M Murter, Lawrence P Kane

|Jul 31, 2025
Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption.

Kristin M Morder, Madison Nguyen, Drew N Wilfahrt

Pageof 6

Frequent Collaborators

4 joint publications

Greg M Delgoffe

3 joint publications

Jishnu Das

3 joint publications

Hector Nieves-Rosado

3 joint publications

Hridesh Banerjee